Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

计划入组 36 人 · 首次发布于 2017 年 3 月 1 日

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

计划入组 7 人 · 首次发布于 2021 年 4 月 30 日

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

计划入组 74 人 · 首次发布于 2019 年 2 月 19 日

KDT-501

KDT-500

KDT-600

AMARA VENTURES

India

Stoh Ventures, Inc.

United States

Endo Ventures Limited

United States

NGM Bio Licenses NGM313 to KdT Ventures for Rare Disease Development

Character Biosciences Secures $110M Series B Extension, Expands Leadership to Advance AMD Therapeutics

Zag Bio Launches with $80 Million to Pioneer Thymus-Targeted Autoimmune Therapies